Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Literature DB >> 20443861

Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Scott A Waldman¹, Andre Terzic.

Abstract

Mesh：

Substances：
Biomarkers

Year: 2009 PMID： 20443861 PMCID： PMC5350787 DOI： 10.1111/j.1752-8062.2008.00067.x

Source DB: PubMed Journal: Clin Transl Sci ISSN： 1752-8054 Impact factor: 4.689

× No keyword cloud information.

21 in total

Review 1. Emerging molecular markers of cancer.

Authors: David Sidransky
Journal: Nat Rev Cancer Date: 2002-03 Impact factor: 60.716

Review 2. The prospects for "personalized medicine" in drug development and drug therapy.

Authors: J Woodcock
Journal: Clin Pharmacol Ther Date: 2007-02 Impact factor: 6.875

3. Oversight of US genetic testing laboratories.

Authors: Kathy L Hudson; Juli A Murphy; David J Kaufman; Gail H Javitt; Sara H Katsanis; Joan Scott
Journal: Nat Biotechnol Date: 2006-09 Impact factor: 54.908

4. Genetic testing oversight.

Authors: Kathy L Hudson
Journal: Science Date: 2006-09-29 Impact factor: 47.728

5. Cancer biomarkers--an invitation to the table.

Authors: William S Dalton; Stephen H Friend
Journal: Science Date: 2006-05-26 Impact factor: 47.728

6. A checklist for evaluating reports of expression profiling for treatment selection.

Authors: Richard Simon
Journal: Clin Adv Hematol Oncol Date: 2006-03

7. A vision of individualized medicine in the context of global health.

Authors: D A Cortese
Journal: Clin Pharmacol Ther Date: 2007-11 Impact factor: 6.875

8. Molecular medicine hones therapeutic arts to science.

Authors: S A Waldman; M R Terzic; A Terzic
Journal: Clin Pharmacol Ther Date: 2007-10 Impact factor: 6.875

9. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors: H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal: N Engl J Med Date: 2001-07-19 Impact factor: 91.245